Investment Summary

GIMV Invests In Anjarium Biosciences

On November 16, 2021, private equity firm GIMV invested in life science company Anjarium Biosciences

Investment Highlights
  • This is GIMV’s 22nd transaction in the Life Science sector.
  • This is GIMV’s 4th transaction in Switzerland.

Investment Summary

Date 2021-11-16
Target Anjarium Biosciences
Sector Life Science
Investor(s) GIMV
Deal Type Venture

Target

Anjarium Biosciences

Schlieren, Switzerland
Anjarium Biosciences is a biotech company focused on creating and delivering a new class of non-viral gene therapies. Anjarium Biosciences was founded in 2017 and is based in Schlieren, Switzerland.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.


DEAL STATS #
Overall 147 of 170
Sector: Life Science M&A 22 of 24
Type: Venture M&A Deals 38 of 39
Country: Switzerland M&A 4 of 5
Year: 2021 M&A 7 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-26 Equipe Zorgbedrijven

Eindhoven, Netherlands

Equipe Zorgbedrijven is an independent group of specialised clinics. The group provides outpatient healthcare in the Netherlands active in hand and wrist surgery & therapy and aesthetic care, with a growing presence in orthopaedics, ophthalmology & general surgery. Equipe Zorgbedrijven was founded in 1995 and is based in Eindhoven, Netherlands.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-01 Ellis

Berchem, Belgium

Ellis is a restaurant chain for hamburger meals, established with the mission to serve the perfect hamburger in a strong service oriented environment. Ellis was founded in 2011 and is based in Berchem, Belgium.

Sell -